$Azitra (AZTR.US)$ Azitra Receives Study May Proceed Letter ...
$Azitra (AZTR.US)$ Azitra Receives Study May Proceed Letter From The FDA For IND To Treat Skin Rash From EGFR Inhibitors
Azitra收到FDA关于IND前行研究的批准信,用于治疗EGFR抑制剂引起的皮疹。
Azitra收到FDA关于IND前行研究的批准信,用于治疗EGFR抑制剂引起的皮疹。
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
买跌不追涨 OP : So disappointing
BFSkinner 买跌不追涨 OP : That’s good news what u mean?
买跌不追涨 OP BFSkinner : Can't you see that it's starting to perform poorly? I found it before the market
BFSkinner 买跌不追涨 OP : Means the blockers were removed to proceed with research study. It might take 2 quarters more to see